RELATING TO INSURANCE -- ACCIDENT AND SICKNESS INSURANCE POLICIES
H7188 amends Rhode Island’s insurance laws to require most health insurance coverage in the state to include diabetes treatment supplies and education, and it updates the existing diabetes coverage mandates across the major insurance chapters. The bill applies to individual and group policies, nonprofit hospital service corporations, nonprofit medical service corporations, and health maintenance organizations. It requires coverage for insulin administration and glucose monitoring equipment and supplies, including items such as blood glucose monitors, test strips, insulin, syringes, pumps, infusion devices, and related appurtenances, as well as medically necessary diabetes self-management education and medical nutrition therapy. It also requires coverage of newly approved diabetes equipment and supplies when medically appropriate and prescribed by a physician.
The bill adds a new cost-sharing limit beginning January 1, 2027: covered persons may not be charged more than $25 for a 30-day supply of insulin administration or glucose monitoring equipment and supplies, or per item if the item is intended to last longer than 30 days. The bill also bars annual deductibles for those items, with a narrow exception intended to preserve health savings account eligibility under federal tax law if applying the cap before the deductible would create an HSA problem. In addition, the bill separately applies the same cap and deductible rule to the state employee health insurance plan when purchased or renewed by the director of administration.
The bill’s impact on state law is to strengthen and standardize diabetes-related insurance benefits across Rhode Island’s regulated health plans and the state employee plan. It would amend multiple chapters of the General Laws governing accident and sickness insurance policies, nonprofit hospital service corporations, nonprofit medical service corporations, and health maintenance organizations, while also creating a new section in the state insurance benefits chapter. The practical effect is to limit out-of-pocket costs for diabetes supplies and monitoring equipment and to require broader coverage for diabetes education and newer FDA-approved supplies.
The available context shows generally supportive or at least non-contentious treatment of the bill, but there is no recorded committee transcript or vote history to indicate debate. The caption and text suggest a consumer-protection and affordability measure aimed at people with diabetes, especially those who rely on insulin and glucose monitoring. Because no votes or hearing remarks are provided, there is no documented opposition in the supplied materials, though the HSA carveout indicates the bill was drafted to avoid conflict with federal tax rules and high-deductible health plan structures.
The bill would amend Rhode Island insurance statutes governing accident and sickness policies, nonprofit hospital service corporations, nonprofit medical service corporations, and health maintenance organizations to require coverage of diabetes treatment equipment, supplies, and medically necessary education. It also adds a new provision for the state employee health insurance plan. Beginning January 1, 2027, it caps patient cost-sharing for insulin administration and glucose monitoring supplies at $25 per 30-day supply or per longer-lasting item and prohibits annual deductibles for those items, subject to a limited HSA-related exception.
The bill appears broadly favorable in purpose and framing, focusing on lowering diabetes-related costs and expanding coverage. The introduced sponsors and the absence of recorded opposition, votes, or committee testimony in the provided materials suggest no visible controversy in the available record. The measure is presented as a consumer affordability and access bill rather than a disputed policy change.
No specific contention is documented in the provided transcripts or voting history because none are included. The only apparent policy tension in the text is the interaction between the new $25 cap and federal health savings account rules, which is addressed through an exception that delays application of the cap until the deductible is met if needed to preserve HSA eligibility. Otherwise, the bill’s requirements are straightforward mandates on insurers and the state employee plan.